Omvårdnadsforskningen i Sverige är en ung vetenskap som i dag är väl etablerad vid landets universitet och högskolor. Många sjuksköterskor på olika befattningar har bidragit till detta liksom ett antal politiska beslut, som till exempel högskolereformen 1977. I dag har omkring 1300 sjuksköterskor disputerat i Sverige, varav 85 innehar professorstjänster eller är professor emerita/emeritus. Hur har denna snabba utveckling varit möjlig? För att belysa det gör här några av de tidiga pionjärerna inom omvårdnadsforskningen en tillbakablick på utvecklingen under de tre första decennierna, åren omkring 1970–2000.

Perioden kännetecknas av entusiasm, viktiga organisatoriska, finansiella och politiska beslut och en övertygelse om behovet av forskningsbaserad kunskap för att ge en kvalitativt god vård och omsorg. Även en avvaktan och ett ifrågasättande av värdet och möjligheten att beforska något så "självklart och praktiskt" som omvårdnadsverksamheten noteras. I boken medverkar sammanlagt 32 författare.

Vi får läsa hur det var att tillhöra de första sjuksköterskorna som genomgick en forskarutbildning, av att vara starkt engagerad i uppbyggnaden av omvårdnadsinstitutioner och får exempel från den tidiga omvårdnadsforskningen under de tre första decennierna. I boken beskrivs också några utbildningsreformer och finansieringssätt - förutsättningar för de första decenniernas omvårdnadsforskning.

Som läsare möter du en idéhistorikers tankar kring tillkomsten av ett nytt ämnesområde och i slutet av boken får du ta del av en sjuksköterska och professors framtidsspaning kring dagens och morgondagens omvårdnadsforskning och dess utmaningar. Boken vänder sig främst till lärare och studenter inom sjuksköterske- och andra vårdutbildningar på grund-, avancerad- och forskarutbildningsnivå samt till kliniskt verksamma och forskare inom hälso-, sjukvård och omsorg.

Sagt om boken”[…] Boken är en intressant dokumentation över ett ungt ämnes etablering som vetenskap.” Motzi Eklöf, lektör, BTJ-häfte 14112229.

"En inspirerande och läsvärd bok för studerande och verksamma inom vården." Läkartidningen. 2014;111:CXWX Lakartidningen.se 2014-05-28, Karin Kjellgren.

Om författarnaRedaktörer för boken När Omvårdnad blev vetenskap är Elisabeth Hamrin och Mona Kihlgren, båda professorer emeritii, Alice Rinell Hermansson, dr. med. Vet. och Gerthrud Östlinder, journalist och filosofie kandidat/magister inom omvårdnad och folkhälsovetenskap, samtliga legitimerade sjuksköterskor. I arbetsgruppen för framtagning av boken har dessutom under hela arbetet ingått Hjördis Björvell, Astrid Norberg, Ulla Qvarnström och Vivian Wahlberg, samtliga legitimerade sjuksköterskor och professorer emeritii.

The later stages of dementia are as important, if not more so, as the earlier stages, since they harbour unique characteristics and events, which profoundly affect the lives of patients and their carers. Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will delay disease progression.  Severe Dementia is the first book to focus exclusively on severe dementia. It addresses both the clinical features of the disease and the social aspects of care. Introductory chapters on the differential diagnosis, neurochemistry and molecular pathology of severe dementia set the scene for the clinical discussion. Detailed clinical chapters on cognitive function, depression, physical effects, staging and function follow. All therapeutic interventions are then discussed, including memantine, anticholinesterases, neuroleptics and non-pharmacological treatment. The final chapters review the social and economic aspects of dementia care, including family involvement, person-centered care, palliative care, ethics and health economics.Written and edited by experts in geriatric psychiatry and geriatrics, Severe Dementia is of value to all clinicians involved in the management of this complex and vulnerable group of patients. It is also of interest to general practitioners and carers in nursing homes.

The later stages of dementia are as important, if not more so, as the earlier stages, since they harbour unique characteristics and events, which profoundly affect the lives of patients and their carers. Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will delay disease progression. 

Severe Dementia is the first book to focus exclusively on severe dementia. It addresses both the clinical features of the disease and the social aspects of care. Introductory chapters on the differential diagnosis, neurochemistry and molecular pathology of severe dementia set the scene for the clinical discussion. Detailed clinical chapters on cognitive function, depression, physical effects, staging and function follow. All therapeutic interventions are then discussed, including memantine, anticholinesterases, neuroleptics and non-pharmacological treatment. The final chapters review the social and economic aspects of dementia care, including family involvement, person-centered care, palliative care, ethics and health economics.

Written and edited by experts in geriatric psychiatry and geriatrics, Severe Dementia is of value to all clinicians involved in the management of this complex and vulnerable group of patients. It is also of interest to general practitioners and carers in nursing homes.

Alzheimer''s Disease is an ever present problem affecting millions of people around the world and, as people''s average lifespan lengthens, its prevalence is set to increase. A global effort is needed to combat the disease, including research to investigate the causes, development of effective treatments and, ultimately, prevention of the disease. Published every two years, these timely books discuss the very latest research. This new volume provides a unique source of reference to the important work being done in this field, it gives academics and clinicians an opportunity to learn about cutting edge developments and covers all aspects of Alzheimer''s Disease, including diagnosis, clinical course, epidemiological course and therapeutics and disease mechanisms. Alzheimer''s Disease: Advances in Etiology, Pathogenesis and Therapeutics will provide essential information for basic and clinical researchers in Alzheimer''s Disease and other dementias as well as for those who care for patients.

Alzheimer's Disease is an ever present problem affecting millions of people around the world and, as people's average lifespan lengthens, its prevalence is set to increase. A global effort is needed to combat the disease, including research to investigate the causes, development of effective treatments and, ultimately, prevention of the disease. Published every two years, these timely books discuss the very latest research. This new volume provides a unique source of reference to the important work being done in this field, it gives academics and clinicians an opportunity to learn about cutting edge developments and covers all aspects of Alzheimer's Disease, including diagnosis, clinical course, epidemiological course and therapeutics and disease mechanisms. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics will provide essential information for basic and clinical researchers in Alzheimer's Disease and other dementias as well as for those who care for patients.

Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. It discusses the challenges of obtaining reliable data and reviews the tools used to assess the costs of dementia to date. It also deals with the pharmacoeconomics of dementia.

Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.

Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.

Omvårdnadsforskningen i Sverige är en ung vetenskap som i dag är väl etablerad vid landets universitet och högskolor. Många sjuksköterskor på olika befattningar har bidragit till detta liksom ett antal politiska beslut, som till exempel högskolereformen 1977. I dag har omkring 1300 sjuksköterskor disputerat i Sverige, varav 85 innehar professorstjänster eller är professor emerita/emeritus. Hur har denna snabba utveckling varit möjlig? För att belysa det gör här några av de tidiga pionjärerna inom omvårdnadsforskningen en tillbakablick på utvecklingen under de tre första decennierna, åren omkring 1970–2000.

Perioden kännetecknas av entusiasm, viktiga organisatoriska, finansiella och politiska beslut och en övertygelse om behovet av forskningsbaserad kunskap för att ge en kvalitativt god vård och omsorg. Även en avvaktan och ett ifrågasättande av värdet och möjligheten att beforska något så "självklart och praktiskt" som omvårdnadsverksamheten noteras. I boken medverkar sammanlagt 32 författare.

Vi får läsa hur det var att tillhöra de första sjuksköterskorna som genomgick en forskarutbildning, av att vara starkt engagerad i uppbyggnaden av omvårdnadsinstitutioner och får exempel från den tidiga omvårdnadsforskningen under de tre första decennierna. I boken beskrivs också några utbildningsreformer och finansieringssätt - förutsättningar för de första decenniernas omvårdnadsforskning.

Som läsare möter du en idéhistorikers tankar kring tillkomsten av ett nytt ämnesområde och i slutet av boken får du ta del av en sjuksköterska och professors framtidsspaning kring dagens och morgondagens omvårdnadsforskning och dess utmaningar. Boken vänder sig främst till lärare och studenter inom sjuksköterske- och andra vårdutbildningar på grund-, avancerad- och forskarutbildningsnivå samt till kliniskt verksamma och forskare inom hälso-, sjukvård och omsorg.

Sagt om boken”[…] Boken är en intressant dokumentation över ett ungt ämnes etablering som vetenskap.” Motzi Eklöf, lektör, BTJ-häfte 14112229.

"En inspirerande och läsvärd bok för studerande och verksamma inom vården." Läkartidningen. 2014;111:CXWX Lakartidningen.se 2014-05-28, Karin Kjellgren.

Om författarnaRedaktörer för boken När Omvårdnad blev vetenskap är Elisabeth Hamrin och Mona Kihlgren, båda professorer emeritii, Alice Rinell Hermansson, dr. med. Vet. och Gerthrud Östlinder, journalist och filosofie kandidat/magister inom omvårdnad och folkhälsovetenskap, samtliga legitimerade sjuksköterskor. I arbetsgruppen för framtagning av boken har dessutom under hela arbetet ingått Hjördis Björvell, Astrid Norberg, Ulla Qvarnström och Vivian Wahlberg, samtliga legitimerade sjuksköterskor och professorer emeritii.

The later stages of dementia are as important, if not more so, as the earlier stages, since they harbour unique characteristics and events, which profoundly affect the lives of patients and their carers. Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will delay disease progression.  Severe Dementia is the first book to focus exclusively on severe dementia. It addresses both the clinical features of the disease and the social aspects of care. Introductory chapters on the differential diagnosis, neurochemistry and molecular pathology of severe dementia set the scene for the clinical discussion. Detailed clinical chapters on cognitive function, depression, physical effects, staging and function follow. All therapeutic interventions are then discussed, including memantine, anticholinesterases, neuroleptics and non-pharmacological treatment. The final chapters review the social and economic aspects of dementia care, including family involvement, person-centered care, palliative care, ethics and health economics.Written and edited by experts in geriatric psychiatry and geriatrics, Severe Dementia is of value to all clinicians involved in the management of this complex and vulnerable group of patients. It is also of interest to general practitioners and carers in nursing homes.

The later stages of dementia are as important, if not more so, as the earlier stages, since they harbour unique characteristics and events, which profoundly affect the lives of patients and their carers. Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will delay disease progression. 

Severe Dementia is the first book to focus exclusively on severe dementia. It addresses both the clinical features of the disease and the social aspects of care. Introductory chapters on the differential diagnosis, neurochemistry and molecular pathology of severe dementia set the scene for the clinical discussion. Detailed clinical chapters on cognitive function, depression, physical effects, staging and function follow. All therapeutic interventions are then discussed, including memantine, anticholinesterases, neuroleptics and non-pharmacological treatment. The final chapters review the social and economic aspects of dementia care, including family involvement, person-centered care, palliative care, ethics and health economics.

Written and edited by experts in geriatric psychiatry and geriatrics, Severe Dementia is of value to all clinicians involved in the management of this complex and vulnerable group of patients. It is also of interest to general practitioners and carers in nursing homes.

Alzheimer''s Disease is an ever present problem affecting millions of people around the world and, as people''s average lifespan lengthens, its prevalence is set to increase. A global effort is needed to combat the disease, including research to investigate the causes, development of effective treatments and, ultimately, prevention of the disease. Published every two years, these timely books discuss the very latest research. This new volume provides a unique source of reference to the important work being done in this field, it gives academics and clinicians an opportunity to learn about cutting edge developments and covers all aspects of Alzheimer''s Disease, including diagnosis, clinical course, epidemiological course and therapeutics and disease mechanisms. Alzheimer''s Disease: Advances in Etiology, Pathogenesis and Therapeutics will provide essential information for basic and clinical researchers in Alzheimer''s Disease and other dementias as well as for those who care for patients.

Alzheimer's Disease is an ever present problem affecting millions of people around the world and, as people's average lifespan lengthens, its prevalence is set to increase. A global effort is needed to combat the disease, including research to investigate the causes, development of effective treatments and, ultimately, prevention of the disease. Published every two years, these timely books discuss the very latest research. This new volume provides a unique source of reference to the important work being done in this field, it gives academics and clinicians an opportunity to learn about cutting edge developments and covers all aspects of Alzheimer's Disease, including diagnosis, clinical course, epidemiological course and therapeutics and disease mechanisms. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics will provide essential information for basic and clinical researchers in Alzheimer's Disease and other dementias as well as for those who care for patients.

Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. It discusses the challenges of obtaining reliable data and reviews the tools used to assess the costs of dementia to date. It also deals with the pharmacoeconomics of dementia.

Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.

Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.